Frontotemporal degeneration

CONTINUUM Lifelong Learning in Neurology

Volumn 16, Issue 2, 2010, Pages 191-211

  Yener, Görsev G ^a   Rosen, Howard J ^a   Papatriantafyllou, John ^a  

^a LUNDBECK RESEARCH USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRANULIN; TAR DNA BINDING PROTEIN; TAU PROTEIN;

APHASIA; ARTICLE; AUTOPSY; BEHAVIOR DISORDER; BRAIN ATROPHY; BRAIN METABOLISM; CHROMOSOME 17; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; FAMILIAL DISEASE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; PARKINSONISM; PRESENILE DEMENTIA; PROGRESSIVE SUPRANUCLEAR PALSY; SYMPTOM; TEMPORAL LOBE;

EID: 78650751799     PISSN: 10802371     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.CON.0000368219.94458.6e     Document Type: Article

References (55)

1. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007;114(1):5-22.
2. Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol 1982;11(6):592-598.
3. Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr 1987;6(3):193-208.
4. Hodges JR, Patterson K, Oxbury S, Funnell E. Semantic dementia: Progressive fluent aphasia with temporal lobe atrophy. Brain 1992;115(pt 6):1783-1806.
5. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994;57(4):416-418.
6. Kertesz A. Frontotemporal dementia, Pick disease, and corticobasal degeneration: One entity or 3? 1. Arch Neurol 1997;54(11):1427-1429.
7. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998;51(6):1546-1554.
8. McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58(11):1803-1809.
9. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442(7105):916-919.
10. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393(6686): 702-705.
11. Neumann M, Tolnay M, Mackenzie IR. The molecular basis of frontotemporal dementia. Expert Rev Mol Med 2009;11:e23.
12. Hatanpaa KJ, Blass DM, Pletnikova O, et al. Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia. Neurology 2004;63(3):538-542.
13. Seeley WW. Selective functional, regional, and neuronal vulnerability in frontotemporal dementia. Curr Opin Neurol 2008;21(6):701-707.
14. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002;58(11):1615-1621.
15. Ikeda M, Ishikawa T, Tanabe H. Epidemiology of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 2004;17(4):265-268.
16. Brunnstrom H, Gustafson L, Passant U, Englund E. Prevalence of dementia subtypes: A 30-year retrospective survey of neuropathological reports. Arch Gerontol Geriatr 2009;49(1):146-149.
17. Rosso SM, Donker Kaat L, Baks T, et al. Frontotemporal dementia in The Netherlands: Patient characteristics and prevalence estimates from a population-based study. Brain 2003;126(pt 9):2016-2022.
18. Mercy L, Hodges JR, Dawson K, et al. Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology 2008;71(19):1496-1499.
19. Roberson ED, Hesse JH, Rose KD, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology 2005;65(5):719-725.
20. Johnson JK, Diehl J, Mendez MF, et al. Frontotemporal lobar degeneration: Demographic characteristics of 353 patients. Arch Neurol 2005;62(6):925-930.
21. Papageorgiou SG, Kontaxis T, Bonakis A, et al. Frequency and causes of early-onset dementia in a tertiary referral center in Athens. Alzheimer Dis Assoc Disord 2009;23(4):347-351.
22. Rosen HJ, Hartikainen KM, Jagust W, et al. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology 2002;58(11):1608-1615.
23. Pijnenburg YA, Mulder JL, van Swieten JC, et al. Diagnostic accuracy of consensus diagnostic criteria for frontotemporal dementia in a memory clinic population. Dement Geriatr Cogn Disord 2008;25(2):157-164.
24. Knopman DS, Boeve BF, Parisi JE, et al. Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol 2005;57(4):480-488.
25. Miller BL, Cummings JL, Villanueva-Meyer J, et al. Frontal lobe degeneration: Clinical, neuropsychological, and SPECT characteristics. Neurology 1991;41(9):1374-1382.
26. Seeley WW, Crawford R, Rascovsky K, et al. Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol 2008;65(2):249-255.
27. Seeley WW, Carlin DA, Allman JM, et al. Early frontotemporal dementia targets neurons unique to apes and humans. Ann Neurol 2006;60(6):660-667.
28. Rosen HJ, Allison SC, Schauer GF, et al. Neuroanatomical correlates of behavioural disorders in dementia. Brain 2005;128(pt 11):2612-2625.
29. Rankin KP, Gorno-Tempini ML, Allison SC, et al. Structural anatomy of empathy in neurodegenerative disease. Brain 2006;129(pt 11):2945-2956.
30. Possin KL, Brambati SM, Rosen HJ, et al. Rule violation errors are associated with right lateral prefrontal cortex atrophy in neurodegenerative disease. J Int Neuropsychol Soc 2009;15(3):354-364.
31. Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004;55(3):335-346.
32. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006;66(1):41-48.
33. Josephs KA, Whitwell JL, Knopman DS, et al. Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology 2009;73(18):1443-1450.
34. Seeley WW, Bauer AM, Miller BL, et al. The natural history of temporal variant frontotemporal dementia. Neurology 2005;64(8):1384-1390.
35. Rosen HJ, Allison SC, Ogar JM, et al. Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology 2006;67(10):1752- 1756.
36. Yokota O, Tsuchiya K, Arai T, et al. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions. Acta Neuropathol 2009;117(4):429-444.
37. Gorno-Tempini ML, Brambati SM, Ginex V, et al. The logopenic/phonological variant of primary progressive aphasia. Neurology 2008;71(16):1227-1234.
38. Gustafson L. Frontal lobe degeneration of non-Alzheimer type. II: Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987;6(3):209-223.
39. Lomen-Hoerth C. Characterization of amyotrophic lateral sclerosis and frontotemporal dementia. Dement Geriatr Cogn Disord 2004;17(4):337-341.
40. Padovani A, Agosti C, Premi E, et al. Extrapyramidal symptoms in frontotemporal dementia: Prevalence and clinical correlations. Neurosci Lett 2007;422(1):39-42.
41. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 1996;47(1):1-9.
42. Boeve B, Dickson D, Duffy J, et al. Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. Eur Neurol 2003;49(2):72-78.
43. Litvan I. Cognitive disturbances in progressive supranuclear palsy. J Neural Transm 1994;42(suppl):69-78.
44. Litvan I, Grimes DA, Lang AE, et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999;246(suppl 2):II1-5.
45. Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 1996;46(4):922-930.
46. Josephs KA. Frontotemporal dementia and related disorders: Deciphering the enigma. Ann Neurol 2008;64(1):4-14.
47. Sha S, Hou C, Viskontas IV, Miller BL. Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases? Nat Clin Pract Neurol 2006;2(12):658-665.
48. Keith-Rokosh J, Ang LC. Progressive supranuclear palsy: A review of co-existing neurodegeneration. Can J Neurol Sci 2008;35(5):602-608.
49. Foulds P, McAuley E, Gibbons L, et al. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration. Acta Neuropathol 2008;116(2):141-146.
50. Arai T, Mackenzie IR, Hasegawa M, et al. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 2009;117(2):125-136.
51. Rohrer JD, Guerreiro R, Vandrovcova J, et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology 2009;73(18):1451-1456.
52. Finch N, Baker M, Crook R, et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 2009;132(pt 3):583-591.
53. Yener GG, Leuchter AF, Jenden D, et al. Quantitative EEG in frontotemporal dementia. Clin Electroencephalogr 1996;27(2):61-68.
54. Passant U, Rosen I, Gustafson L, Englund E. The heterogeneity of frontotemporal dementia with regard to initial symptoms, qEEG and neuropathology. Int J Geriatr Psychiatry 2005;20(10):983-988.
55. Bian H, Van Swieten JC, Leight S, et al. CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 2008;70(19 pt 2):1827-1835.